Skip to main content

Opioid Crisis: Hard-Hit Counties Opt For Individual Lawsuit

Opioid Crisis: Hard-Hit Counties Opt For Individual Lawsuit

Opioid Crisis: Hard-Hit Counties Opt For Individual Lawsuit

Introduction

The opioid class action, created to help settle thousands of lawsuits, has been weakened after the local governments in regions affected by the opioid epidemic opted to move forward with individual lawsuits against the drug industries involved.

According to a Monday court filing, the 541 local governments that opted out include Florida’s Palm Beach County and counties in West Virginia, which are among the hardest-hit areas. Houston’s Harris County, one of the largest U.S. counties, also opted out and has agreed to not receive funds from a nationwide settlement.

Altogether, 98% of some 34,000 local governments agreed to move forward with the class action against drug distributor McKesson Corp, drugmaker Johnson & Johnson, and pharmacy chain Walgreens Boots Alliance Inc.

Companies manufacturing opioids convinced the medical community that these medications were not addictive and were purely beneficial. This belief raised the number of prescriptions and sales unwarrantedly, resulting in a mass misuse of these drugs, to the extent that this was identified by the U.S. Food and Drug Administration (FDA) as a public issue and named it an opioid crisis.

More than 2,600 lawsuits are alleging the defendants fueled the opioid crisis and contributed to 400,000 U.S. deaths between 1999 and 2017. U.S. District Judge Dan Polster is presiding over the opioid lawsuits consolidated under MDL No. 2804 (In Re: National Prescription Opiate Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.